BriaCell Therapeutics Corp. SEC filings BCTXZ
BriaCell Therapeutics Corp. has 324 filings in SEC EDGAR's recent list, going back to Jun 20, 2014. Its latest annual report, Form 10-K, was filed on Oct 28, 2026 for the period ended Jul 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 9, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Jun 26, 2026 (regulation fd disclosure). The company's fiscal year ends on July 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Oct 28, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2026 | Jun 26, 2026 |
| 10-Q | Quarterly report | Jun 9, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 3, 2026 | May 31, 2026 |
| 424B5 | Prospectus supplement | Jun 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Mar 10, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 9, 2026 | Mar 5, 2026 |
| 25-NSE | Delisting notice | Feb 26, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 20, 2026 | Feb 18, 2026 |
| DEF 14A | Proxy statement | Feb 12, 2026 | Feb 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 23, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jan 15, 2026 | Jan 13, 2026 |
| 424B4 | Prospectus | Jan 14, 2026 | — |
| EFFECT | Filing | Jan 13, 2026 | — |
| S-1MEF | Filing | Jan 13, 2026 | — |
| CERT | Filing | Jan 13, 2026 | — |
| 8-A12B | Filing | Jan 13, 2026 | — |
| CORRESP | Letter to the SEC | Jan 8, 2026 | — |
| CORRESP | Letter to the SEC | Jan 8, 2026 | — |
| CORRESP | Letter to the SEC | Jan 6, 2026 | — |
| CORRESP | Letter to the SEC | Jan 6, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 29, 2025 | Dec 29, 2025 |
| FWP | Free writing prospectus | Dec 23, 2025 | — |
| S-1 | Registration statement | Dec 23, 2025 | — |
| 10-Q | Quarterly report | Dec 11, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 1, 2025 | Nov 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| DRSLTR | Filing | Oct 16, 2025 | — |
| DRS | Filing | Oct 16, 2025 | — |
| 10-K | Annual report | Oct 16, 2025 | Jul 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 10, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 26, 2025 | Aug 21, 2025 |
| S-8 | Employee stock plan registration | Aug 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 22, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 21, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 16, 2025 | Jul 15, 2025 |
| 424B4 | Prospectus | Jul 16, 2025 | — |
| EFFECT | Filing | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 14, 2025 | — |
| CORRESP | Letter to the SEC | Jul 14, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| FWP | Free writing prospectus | Jul 11, 2025 | — |
| S-1/A | Amended registration statement | Jul 10, 2025 | — |
| S-1/A | Amended registration statement | Jul 9, 2025 | — |
| FWP | Free writing prospectus | Jul 8, 2025 | — |
| CORRESP | Letter to the SEC | Jul 8, 2025 | — |
| CORRESP | Letter to the SEC | Jul 8, 2025 | — |
| S-1 | Registration statement | Jul 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2025 | — |
| DRSLTR | Filing | Jun 18, 2025 | — |
| DRS | Filing | Jun 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2025 | Jun 16, 2025 |
| 10-Q | Quarterly report | Jun 16, 2025 | Apr 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 28, 2025 | Apr 24, 2025 |
| 424B4 | Prospectus | Apr 28, 2025 | — |
| 424B4 | Prospectus | Apr 28, 2025 | — |
| EFFECT | Filing | Apr 24, 2025 | — |
| S-1MEF | Filing | Apr 24, 2025 | — |
| CERT | Filing | Apr 24, 2025 | — |
| 8-A12B | Filing | Apr 24, 2025 | — |
| S-1/A | Amended registration statement | Apr 23, 2025 | — |
| FWP | Free writing prospectus | Apr 22, 2025 | — |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| S-1 | Registration statement | Apr 22, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| DRSLTR | Filing | Mar 12, 2025 | — |
| DRS | Filing | Mar 12, 2025 | — |
| 10-Q | Quarterly report | Mar 12, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2025 | Mar 12, 2025 |
| 8-K |
Current report
Other events
|
Feb 13, 2025 | Feb 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Feb 6, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 5, 2025 | Feb 3, 2025 |
| 424B5 | Prospectus supplement | Feb 4, 2025 | — |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 28, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Other events
|
Jan 3, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Other events
|
Jan 3, 2025 | Jan 3, 2025 |
| DEFA14A | Additional proxy material | Jan 3, 2025 | — |
| DEF 14A | Proxy statement | Dec 17, 2024 | Dec 17, 2024 |
| 10-Q | Quarterly report | Dec 16, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 13, 2024 | Dec 11, 2024 |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 12, 2024 | — |
| 424B5 | Prospectus supplement | Dec 11, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 10, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 5, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 25, 2024 | Nov 23, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 1, 2024 | Nov 1, 2024 |
| 10-K | Annual report | Oct 29, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 2, 2024 | Oct 1, 2024 |
| 424B5 | Prospectus supplement | Oct 2, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 1, 2024 | Oct 1, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 16, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 12, 2024 | Sep 11, 2024 |
| 424B5 | Prospectus supplement | Sep 12, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 11, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 23, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 18, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2024 | Jul 3, 2024 |
| 10-Q | Quarterly report | Jun 14, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2024 | Jun 14, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 24, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 14, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 17, 2024 | May 14, 2024 |
| 424B5 | Prospectus supplement | May 16, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2024 | Apr 1, 2024 |
| 10-Q | Quarterly report | Mar 18, 2024 | Jan 31, 2024 |
| EFFECT | Filing | Jan 31, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jan 31, 2024 | Jan 30, 2024 |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2024 | — |
| S-3 | Shelf registration | Jan 22, 2024 | — |
| DEF 14A | Proxy statement | Jan 9, 2024 | Jan 9, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 10-Q | Quarterly report | Dec 14, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2023 | Nov 3, 2023 |
| 10-K | Annual report | Oct 25, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2023 | Oct 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 7, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Aug 25, 2023 | Aug 25, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Aug 21, 2023 | Aug 18, 2023 |
| DEF 14A | Proxy statement | Jul 26, 2023 | Jul 26, 2023 |
| PRE 14A | Preliminary proxy statement | Jun 30, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2023 | Jun 27, 2023 |
| 10-Q | Quarterly report | Jun 14, 2023 | Apr 30, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 31, 2023 | May 24, 2023 |
| 8-K |
Current report
Unregistered share sale
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Material agreement
|
May 15, 2023 | May 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2023 | Mar 30, 2023 |
| EFFECT | Filing | Mar 28, 2023 | — |
| POS AM | Filing | Mar 20, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2023 | — |
| 10-Q | Quarterly report | Mar 16, 2023 | Jan 31, 2023 |
| CORRESP | Letter to the SEC | Mar 13, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 8, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Feb 15, 2023 | Feb 9, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 24, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 18, 2023 | Jan 18, 2023 |
| DEF 14A | Proxy statement | Jan 17, 2023 | Jan 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| PRE 14A | Preliminary proxy statement | Jan 5, 2023 | Jan 5, 2023 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 28, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 20, 2022 |
| 10-Q | Quarterly report | Dec 14, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-K | Annual report | Oct 28, 2022 | Jul 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 28, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 21, 2022 | Oct 21, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2022 | Sep 14, 2022 |
| 3 | Initial insider ownership | Aug 11, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Material agreement
|
Aug 4, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 2, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| SC 13G | Ownership over 5% (passive) | Aug 1, 2022 | — |
| 6-K | Current report (foreign issuer) | Jul 18, 2022 | Jul 18, 2022 |
| 6-K | Current report (foreign issuer) | Jul 5, 2022 | Jul 5, 2022 |
| 6-K | Current report (foreign issuer) | Jun 29, 2022 | Jun 29, 2022 |
| 6-K | Current report (foreign issuer) | Jun 24, 2022 | Jun 24, 2022 |
| 6-K | Current report (foreign issuer) | Jun 13, 2022 | Apr 30, 2022 |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| SC 13G | Ownership over 5% (passive) | Apr 25, 2022 | — |
| 6-K | Current report (foreign issuer) | Apr 13, 2022 | Apr 13, 2022 |
| 6-K | Current report (foreign issuer) | Apr 12, 2022 | Apr 12, 2022 |
| 6-K | Current report (foreign issuer) | Apr 7, 2022 | Apr 7, 2022 |
| 424B3 | Prospectus | Mar 21, 2022 | — |
| EFFECT | Filing | Mar 16, 2022 | — |
| 6-K | Current report (foreign issuer) | Mar 15, 2022 | Jan 31, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BCTX (Nasdaq), BCTXL (Nasdaq), BCTXZ (Nasdaq)
- Fiscal year ends
- July 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- West Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1610820
- Former names
- Ansell Capital Corp. (until Jun 20, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.